Stocks
Avanos Medical (AVNS) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 6.57% | 11.4% | 7.52% | -50.2% | -4.73% | -2.58% | ||
| Changes by years, y/y, % | +7pp | +5pp | -4pp | -58pp | +46pp | +76.1% | |||
Avanos Medical. EBITDA margin, %
Avanos Medical. EBITDA margin, changes, pp
Avanos Medical (AVNS) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 12.8% | -36.5% | 5.62% | 7.19% | 12.3% | -2.58% | |
| Changes by years, y/y, % | +3pp | -49pp | -9pp | +234pp | 0pp | |||
| Changes by quarters, q/q, % | +239pp | -49pp | +42pp | +2pp | +5pp | |||
